Over the last 20 years Rod has been involved in all aspects of clinical trials, global drug development and organizational design within the pharmaceutical and allied industries. Rod completed his MSc in Clinical Trial Methodology at McMaster University and his MBA at Queen’s University.
SPEAKER
(S):
Adam Chasse, MHA (SPKNON), Chief Operating Officer, RxTrials, Inc., United States
Mr. Chasse has 18 years experience in the CRO and site segments of the industry, during which he pioneered the concepts of site partnerships and data-driven site performance management. He has developed and managed pharma/healthcare strategic alliances in the US, Africa, Asia Pac, and Europe.
Andrew Townshend, (SCHNON), Vice President, Alliance Development, INC Research, United States
Vice President of Alliance Development at INC Research. Mr. Townshend has responsibility for developing strategic accounts within the Pharma and biotech industries focused on novel and innovative engagement and alliance models. Prior to this, Mr. Townshend was Vice President Outsourcing at Pfizer .
Jessica Dolfi, MS (SPKNON), Senior Business Consultant II, Medidata Solutions Worldwide, United States
Jessica brings nearly a decade of experience working with dozens of global life science companies to increase efficiency and control costs of running clinical trials. Jessica received a M.S./B.S. in research-based psychology with a minor in business from St. Joseph’s University in Philadelphia.
Description
Financial pressures are increasing at both the sponsor level and the site level. The implementation of sophisticated models and the introduction of Fair Market Value make study evaluation and discussions more challenging for sites and sponsors.